deltatrials
Recruiting PHASE2 INTERVENTIONAL 2-arm NCT04307953

Saracatinib Trial TO Prevent FOP (STOPFOP)

Sponsor: Amsterdam UMC, location VUmc

Conditions Fibrodysplasia Ossificans Progressiva
Interventions AZD0530 Difumarate Matching placebo
Updated 9 times since 2020 Last updated: May 2, 2024 Started: Aug 5, 2020 Primary completion: May 6, 2025 Completion: May 6, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Fibrodysplasia Ossificans Progressiva, this trial is actively recruiting participants. The trial is conducted by Amsterdam UMC, location VUmc and has accumulated 9 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Apr 2020 – ~Jun 2020 · 2 months · monthly snapshotRecruiting~Jun 2020 – ~Nov 2020 · 5 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotRecruiting~Jan 2021 – ~May 2022 · 16 months · monthly snapshotRecruiting~May 2022 – ~Sep 2022 · 4 months · monthly snapshotRecruiting~Sep 2022 – ~Jun 2024 · 21 months · monthly snapshotRecruiting~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – present · 23 months · monthly snapshotRecruiting

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  3. Jun 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  4. Sep 2022 — Jun 2024 [monthly]

    Recruiting PHASE2

  5. May 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

▶ Show 4 earlier versions

  1. Jan 2021 — May 2022 [monthly]

    Recruiting PHASE2

  2. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  3. Jun 2020 — Nov 2020 [monthly]

    Recruiting PHASE2

  4. Apr 2020 — Jun 2020 [monthly]

    Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Amsterdam UMC, location VUmc
  • AstraZeneca
  • Brigham and Women's Hospital
  • Innovative Medicines Initiative
  • Klinikum Garmisch-Patenkirchen
  • Royal National Orthopaedic Hospital NHS Trust
  • University of Oxford
Data source: Amsterdam UMC, location VUmc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations